Filing Details
- Accession Number:
- 0000897069-23-001044
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-08-01 17:10:16
- Reporting Period:
- 2022-12-06
- Accepted Time:
- 2023-08-01 17:10:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1729427 | Cns Pharmaceuticals Inc. | CNSP | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1678516 | Waldemar Priebe | C/O Cns Pharmaceuticals, Inc. 100 West Loop South, Suite 900 Houston TX 77027 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-12-06 | 5,500 | $2.47 | 245,605 | No | 4 | S | Indirect | See footnote |
| Common Stock | Disposition | 2022-12-07 | 5,500 | $2.46 | 240,105 | No | 4 | S | Indirect | See footnote |
| Common Stock | Disposition | 2022-12-08 | 5,500 | $2.40 | 234,605 | No | 4 | S | Indirect | See footnote |
| Common Stock | Disposition | 2022-12-09 | 2,798 | $2.43 | 231,807 | No | 4 | S | Indirect | See footnote |
| Common Stock | Disposition | 2023-03-10 | 5,000 | $1.29 | 226,807 | No | 4 | S | Indirect | See footnote |
| Common Stock | Disposition | 2023-03-13 | 5,000 | $1.30 | 221,807 | No | 4 | S | Indirect | See footnote |
| Common Stock | Disposition | 2023-03-14 | 5,000 | $1.35 | 216,807 | No | 4 | S | Indirect | See footnote |
| Common Stock | Disposition | 2023-03-15 | 5,000 | $1.22 | 211,807 | No | 4 | S | Indirect | See footnote |
| Common Stock | Disposition | 2023-03-16 | 5,000 | $1.24 | 206,807 | No | 4 | S | Indirect | See footnote |
| Common Stock | Disposition | 2023-03-17 | 5,000 | $1.13 | 201,807 | No | 4 | S | Indirect | See footnote |
| Common Stock | Disposition | 2023-03-20 | 5,000 | $1.08 | 196,807 | No | 4 | S | Indirect | See footnote |
| Common Stock | Disposition | 2023-03-21 | 5,000 | $1.10 | 191,807 | No | 4 | S | Indirect | See footnote |
| Common Stock | Disposition | 2023-03-22 | 5,000 | $1.08 | 186,807 | No | 4 | S | Indirect | See footnote |
| Common Stock | Disposition | 2023-03-23 | 10,000 | $1.08 | 176,807 | No | 4 | S | Indirect | See footnote |
| Common Stock | Disposition | 2023-03-24 | 5,000 | $1.08 | 171,807 | No | 4 | S | Indirect | See footnote |
| Common Stock | Disposition | 2023-03-27 | 5,000 | $1.09 | 166,807 | No | 4 | S | Indirect | See footnote |
| Common Stock | Disposition | 2023-03-28 | 10,000 | $1.04 | 156,807 | No | 4 | S | Indirect | See footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | See footnote |
| No | 4 | S | Indirect | See footnote |
| No | 4 | S | Indirect | See footnote |
| No | 4 | S | Indirect | See footnote |
| No | 4 | S | Indirect | See footnote |
| No | 4 | S | Indirect | See footnote |
| No | 4 | S | Indirect | See footnote |
| No | 4 | S | Indirect | See footnote |
| No | 4 | S | Indirect | See footnote |
| No | 4 | S | Indirect | See footnote |
| No | 4 | S | Indirect | See footnote |
| No | 4 | S | Indirect | See footnote |
| No | 4 | S | Indirect | See footnote |
| No | 4 | S | Indirect | See footnote |
| No | 4 | S | Indirect | See footnote |
| No | 4 | S | Indirect | See footnote |
| No | 4 | S | Indirect | See footnote |
Footnotes
- Consists of: (i) shares of common stock held by a limited liability company; and (ii) shares held by Houston Pharmaceuticals, Inc.
Billionaire Hedge Funds
